Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children

Vaccine

Volumn 19, Issue 20-22, 2001, Pages 2819-2824

  Avanzini, Maria Antonietta ^a   Belloni, Cesare ^a   Soncini, Renato ^b   Ciardelli, Laura ^a   De Silvestri, Annalisa ^a   Pistorio, Angela ^a   Tinelli, Carmine ^a   Maccario, Rita ^a   Rondini, Giorgio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Dipartimento Clinico   (Italy)

Author keywords

Bulk culture; Proliferating T lymphocyte precursors; Stimulation index

Indexed keywords

HEPATITIS B VACCINE; MEMBRANE ANTIGEN; RECOMBINANT VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BIRTH; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

HEMATOPOIETIC STEM CELLS; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 0035815508     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00007-X     Document Type: Article

References (22)

1. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings
2. Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States
3. Hepatitis B vaccine in health care personnel: Safety, immunogenicity and indicators of efficacy
4. Risk factors for lack of detectable antibody following hepatitis B vaccination in Minnesota health care workers
5. Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early
6. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination
7. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired allorectivity
8. Humoral response to recombinant hepatitis B virus vaccine at birth: Role of HLA and beyond
9. Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children
10. Scheduling of revaccination against hepatitis B virus
11. Immunantwort auf nachimpfungen mit einer rekombinanten Hepatitis-B-Vakzine bei low- und non-respondern
12. Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine
13. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders
14. Defect in Th1-like cells of nonresponders to hapatitis B vaccine
15. Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis vaccine
16. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines
17. Limiting dilution analysis of human T-cells: A useful clinical tool
18. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis
19. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T-cells in allogeneic bone marrow transplantation recipients
20. Self-nonself discrimination by T-cells
21. The non-MHC transplantation antigens: Neither weak nor minor
22. The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination